Increased soluble Fas plasma levels in subjects at high cardiovascular risk. Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST. - Blanco-Colio,L.M.; Martín-Ventura,J.L.; de Teresa,E. (Arterioscler Thromb Vasc Biol, 2007)